Publications by authors named "M Sorribas"

Surgical resection for ampullary lesions lacks clear guidelines. Pancreaticoduodenectomy (PD) is the standard treatment for malignant ampullary tumors but is often excessive for ampullary adenomas (AAs) due to its high morbidity and mortality. Transduodenal ampullectomy (TDA) is generally reserved for small benign lesions where endoscopic treatment fails, but its role in early ampullary cancers is debatable.

View Article and Find Full Text PDF
Article Synopsis
  • Atmospheric new particle formation (NPF) is the natural process of creating tiny particles (sub-10 nm) from gases, observed globally in various environments.
  • Although these particles impact total and ultrafine particle concentrations, there is limited research on their health effects largely due to a lack of specific identifiers in existing data.
  • This study introduces an automated machine learning algorithm that identifies NPF events from particle data across 65 global measurement sites from 1996 to 2023, facilitating future research on NPF.
View Article and Find Full Text PDF

Introduction: Embolization could increase the resectability of pancreatic tumors by supercharging visceral arterial perfusion prior to pancreatic surgery with arterial en-bloc resection. Its indications, however, are controversial.

Methods: We retrospectively analyzed the results of a single-center database of patients undergoing pancreatic surgery with arterial resection (AR) after preoperative arterial embolization (PAE) to increase hepatic vascular flow and spare arterial reconstruction.

View Article and Find Full Text PDF

Risk assessment of pesticide impacts on remote ecosystems makes use of model-estimated degradation in air. Recent studies suggest these degradation rates to be overestimated, questioning current pesticide regulation. Here, we investigated the concentrations of 76 pesticides in Europe at 29 rural, coastal, mountain, and polar sites during the agricultural application season.

View Article and Find Full Text PDF

Introduction: Borderline Resectable Pancreatic Ductal Adenocarcinoma (BR-PDAC) benefits from neoadjuvant treatment (NAT) with the intent of surgical salvage in the absence of disease progression during chemotherapy (CT) or chemoradiotherapy (CRT). Scarce literature exists about prognostic factors of resectability at the time of diagnosis or during neoadjuvant treatment, especially regarding vascular relationships.

Materials: We reviewed our prospective BR-PDAC cohort to determine resectability predictors.

View Article and Find Full Text PDF